Gaurav Shah - 13 Feb 2026 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
CEO
Signature
/s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
Issuer symbol
RCKT
Transactions as of
13 Feb 2026
Net transactions value
-$40,668
Form type
4
Filing time
18 Feb 2026, 17:33:30 UTC
Previous filing
13 Feb 2026
Next filing
20 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shah Gaurav CEO C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY /s/ Martin Wilson, as attorney-in-fact for Gaurav Shah 18 Feb 2026 0001725922

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale $40,668 -12,279 -1.2% $3.31 1,052,045 13 Feb 2026 Direct F1, F2
holding RCKT Common Stock 207,897 13 Feb 2026 By Spouse
holding RCKT Common Stock 198,341 13 Feb 2026 By Gaurav D. Shah Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.